[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2023 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Dec-2023 [#4]
Profit Trend
QoQ- 19.26%
YoY- -24.91%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 620,024 411,292 192,968 704,727 537,226 367,991 200,475 111.83%
PBT 62,581 42,061 20,101 63,267 56,233 44,805 28,292 69.52%
Tax -15,019 -10,095 -4,824 -10,622 -12,090 -9,633 -5,659 91.35%
NP 47,562 31,966 15,277 52,645 44,143 35,172 22,633 63.84%
-
NP to SH 47,562 31,966 15,277 52,645 44,143 35,172 22,633 63.84%
-
Tax Rate 24.00% 24.00% 24.00% 16.79% 21.50% 21.50% 20.00% -
Total Cost 572,462 379,326 177,691 652,082 493,083 332,819 177,842 117.54%
-
Net Worth 693,211 692,598 682,979 682,979 673,359 670,448 666,567 2.64%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 9,627 9,619 - 22,124 4,809 4,788 - -
Div Payout % 20.24% 30.09% - 42.03% 10.90% 13.62% - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 693,211 692,598 682,979 682,979 673,359 670,448 666,567 2.64%
NOSH 962,793 961,942 961,942 961,942 961,942 961,942 952,239 0.73%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 7.67% 7.77% 7.92% 7.47% 8.22% 9.56% 11.29% -
ROE 6.86% 4.62% 2.24% 7.71% 6.56% 5.25% 3.40% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 64.40 42.76 20.06 73.26 55.85 38.42 21.05 110.31%
EPS 4.94 3.32 1.59 5.49 4.61 3.68 2.38 62.50%
DPS 1.00 1.00 0.00 2.30 0.50 0.50 0.00 -
NAPS 0.72 0.72 0.71 0.71 0.70 0.70 0.70 1.89%
Adjusted Per Share Value based on latest NOSH - 961,942
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 64.41 42.72 20.05 73.21 55.81 38.23 20.83 111.81%
EPS 4.94 3.32 1.59 5.47 4.59 3.65 2.35 63.87%
DPS 1.00 1.00 0.00 2.30 0.50 0.50 0.00 -
NAPS 0.7201 0.7195 0.7095 0.7095 0.6995 0.6965 0.6924 2.64%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 1.36 1.26 1.20 1.26 1.20 1.30 1.56 -
P/RPS 2.11 2.95 5.98 1.72 2.15 3.38 7.41 -56.61%
P/EPS 27.53 37.92 75.56 23.02 26.15 35.40 65.63 -43.87%
EY 3.63 2.64 1.32 4.34 3.82 2.82 1.52 78.38%
DY 0.74 0.79 0.00 1.83 0.42 0.38 0.00 -
P/NAPS 1.89 1.75 1.69 1.77 1.71 1.86 2.23 -10.41%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 08/11/24 15/08/24 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 -
Price 1.25 1.17 1.26 1.21 1.22 1.19 1.44 -
P/RPS 1.94 2.74 6.28 1.65 2.18 3.10 6.84 -56.73%
P/EPS 25.30 35.21 79.34 22.11 26.59 32.41 60.59 -44.04%
EY 3.95 2.84 1.26 4.52 3.76 3.09 1.65 78.66%
DY 0.80 0.85 0.00 1.90 0.41 0.42 0.00 -
P/NAPS 1.74 1.62 1.77 1.70 1.74 1.70 2.06 -10.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment